Company Overview
| Stock Name | RMH Holdings |
|---|---|
| Stock Code | 08437 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 我們為獲新加坡衛生部正式認可的領先皮膚及外科專科診所,專門針對影響皮膚、頭髮及指甲的各種皮膚問題,採用一系列先進完善的醫療、外科、激光及美容療程,提供方便全面而優質的專業護理服務。主要提供諮詢服務、處方及配藥服務、療程服務(外科療程、微創/無創療程)及其他服務。 |
| Listing Date | 2017-10-13 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港皇后大道中183號中遠大廈9樓911室 |
| Business Address (Hong Kong) | 香港皇后大道中99號中環中心57樓5705室 |
| Place of Incorporation | 開曼群島 |
| Listing Method | 發售以供認購 + 發售以供配售 |
| Listing Board | GEM |
| Website | dermclinic.com.sg |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 0.48 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2017-09-29 to 2017-10-06 |
| Global Offering Shares | 150,000,000 shares |
| HK Public Offer Shares (Initial) | 15,000,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 135,000,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 600,000,000 shares |
| Greenshoe (Over-allotment Option) | No |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | No |
| Total Global Offering Size | HK$ 72,000,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 17.3M |
| Est. Threshold | HK$ 9.73B |
| Analysis Result | HK market cap below threshold, need +56282% |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 288,000,000 |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約2.681百萬新加坡元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2015 | 2016 | 2017-03 |
|---|---|---|---|
| Revenue | 5,596 | 6,160 | 1,609 |
| Other income and gains, net | 33 | 168 | 19 |
| Net finance costs | -7 | -8 | -2 |
| Profit before tax | 2,579 | 3,044 | 237 |
| Income tax expense | -328 | -363 | -43 |
| Profit for the year | 2,251 | 2,681 | 194 |
| Profit attributable to owners | 2,251 | 2,681 | 194 |
Balance Sheet
| Item | 2015 | 2016 | 2017-03 |
|---|---|---|---|
| Cash and cash equivalents | 816 | 478 | 1,665 |
| Trade and bills receivables | 350 | 612 | 815 |
| Inventories | 158 | 149 | 171 |
| Total current assets | 1,324 | 1,239 | 2,651 |
| Total current liabilities | 873 | 1,050 | 2,240 |
| Total equity | 764 | 436 | 630 |
| Equity attributable to owners | 764 | 436 | 630 |
| Interest-bearing borrowings | 392 | 281 | 253 |
Cash Flow Statement
| Item | 2015 | 2016 | 2017-03 |
|---|---|---|---|
| Net cash from operating activities | 3,194 | 2,838 | 312 |
| Net cash from investing activities | -124 | -48 | 0 |
| Net cash from financing activities | -3,012 | -3,128 | 875 |
| Net increase in cash | 58 | -338 | 1,187 |
| Depreciation of PP&E | 215 | 221 | 56 |
| Purchase of PP&E | -124 | -48 | 0 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 0.68 |
|---|---|
| First Day Open | HK$ 0.57 |
| First Day Change | 41.67% |
| First Day Volume | 138120000.0 |
| First Day Turnover | 80706800.0 |
| Use of Proceeds | 1、約14.7百萬港元或約31.6%將用作策略性地擴展及加強本集團在新加坡的診所網絡;
2、約14.1百萬港元或約30.4%將用作提升本集團現有診所的質素及服務種類及成立新醫學美容診所;
3、約9.9百萬港元或約21.4%將用作購買額外新器材并擴大所提供療程、程序及產品種類;
4、約2.4百萬港元或約5.1%將用作建立中央運作的物流中心;
5、約2.5百萬港元或約5.4%將用作改善本集團的信息科技基礎設施及系統;
6、約2.8百萬港元或約6.1%將用作本集團的一般營運資金。 |
Underwriting Syndicate
Sole Sponsor (1)
LY CAPITAL LIMITED CE BBT182
Joint Bookrunners (1)
GAOYU SECURITIES LIMITED CE AAE696
Joint Lead Managers (1)
GAOYU SECURITIES LIMITED CE AAE696
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | Loh Teck Hiong | — |
| Company Secretary | 文潤華 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Brisk Success持有405,000,000股,佔67.5%;Loh醫生、Ee醫生及柯醫生各自透過Brisk Success被視為擁有權益,各佔67.5%;妙濤持有45,000,000股,佔7.5%;王醫生透過妙濤擁有權益;黄藹怡女士配偶權益佔7.5%。 |
|---|




